Psammaplysins: Insights from Natural Sources, Structural Variations, and Pharmacological Properties

Mar Drugs. 2022 Oct 25;20(11):663. doi: 10.3390/md20110663.

Abstract

Marine natural products (MNPs) continue to be in the spotlight in the global drug discovery endeavor. Currently, more than 32,000 structurally diverse secondary metabolites from marine sources have been isolated, making MNPs a vital source for researchers to look for novel drug candidates. The marine-derived psammaplysins possess the rare and unique 1,6-dioxa-2-azaspiro [4.6] undecane backbone and are represented by 44 compounds in the literature, mostly from sponges of the order Verongiida. Compounds with 1,6-dioxa-2-azaspiro [4.6] undecane moiety exist in the literature under five names, including psammaplysins, ceratinamides, frondoplysins, ceratinadins, and psammaceratins. These compounds displayed significant biological properties including growth inhibitory, antimalarial, antifouling, protein tyrosine phosphatase inhibition, antiviral, immunosuppressive, and antioxidant effects. In this review, a comprehensive literature survey covering natural occurrence of the psammaplysins and related compounds, methods of isolation, structural differences, the biogenesis, and biological/pharmacological properties, will be presented.

Keywords: 1,6-dioxa-2-azaspiro[4.6]undecane backbone; isolation; marine alkaloids; natural occurrence; pharmacological properties; semisynthesis; structural variations.

Publication types

  • Review

MeSH terms

  • Alkanes
  • Antimalarials* / pharmacology
  • Biological Products* / chemistry
  • Drug Discovery

Substances

  • undecane
  • Biological Products
  • Alkanes
  • Antimalarials